|
3rd Annual Pharmaceutical Product Complaints
Ensure Regulatory Compliance and Minimize Legal Exposure by Managing the Process
3rd Annual Pharmaceutical Product Complaints
PHILADELPHIA - The FDA does not provide a clear guidance that explains when a product complaint needs to be investigated, what information to include in a complaint response letter or requirements for trending and data analysis. In the absence of FDA guidance, pharmaceutical professionals are looking to others in the industry to learn how they handle these situations. CBI conferences provide an excellent environment for interactive discussion and networking.
Preparing and passing an FDA inspection
Discerning responsibility for counterfeit products and complaints
Expectations for product testing
Call center management of complaints
Strategies to develop a globally compliant system
Managing product complaints through quality concepts
Plus! Special Symposium: Road Mapping the Complaints Process
| 
